SCA
PDLI

SMH Capital Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

SMH Capital Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-162,336
Closed -$511K – 51
2020
Q3 		$511K Buy
162,336
+84,629
+109% +$270K 1.19% 8
2020
Q2 		$226K Buy
77,707
+919
+1% +$2.91K 0.45% 23
2020
Q1 		$217K Sell
76,788
-3,275
-4% -$10.6K 0.46% 19
2019
Q4 		$260K Sell
80,063
-1,650
-2% -$4.79K 0.52% 22
2019
Q3 		$176K Sell
81,713
-3,655
-4% -$9.77K 0.39% 30
2019
Q2 		$268K Hold
85,368
– – 0.65% 23
2019
Q1 		$318K Buy
85,368
+2,009
+2% +$6.78K 0.62% 19
2018
Q4 		$242K Sell
83,359
-10,349
-11% -$28.4K 0.49% 20
2018
Q3 		$246K Buy
93,708
+10,339
+12% +$25.4K 0.42% 25
2018
Q2 		$195K Buy
83,369
+2,647
+3% +$7.39K 0.32% 27
2018
Q1 		$237K Buy
80,722
+785
+1% +$2.14K 0.37% 25
2017
Q4 		$219K Buy
+79,937
New +$246K 0.37% 26

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

SMH Capital Advisors's PDLI Position: Q4 2020 in Review

SMH Capital Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 162,336 shares — an estimated $511K sold.

SMH Capital Advisors first reported a position in PDLI in Q4 2017 and held it in 12 quarters. The position peaked at $511K in Q3 2020. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • SMH Capital Advisors reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • SMH Capital Advisors sold 162,336 PDL BioPharma, Inc. shares in Q4 2020, an estimated $511K.
  • SMH Capital Advisors first reported a position in PDL BioPharma, Inc. in Q4 2017 and held it in 12 quarters.
  • SMH Capital Advisors's PDL BioPharma, Inc. position peaked at $511K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on SMH Capital Advisors's 13F filing for Q4 2020, filed 20 Jan 2021.